Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Repurposing pexmetinib as an inhibitor of TKI-resistant BCR::ABL1
Leukemia ( IF 12.8 ) Pub Date : 2024-05-15 , DOI: 10.1038/s41375-024-02282-y Diletta Fontana 1 , Federica Malighetti 1 , Matteo Villa 1 , Alfonso Zambon 2 , Carlo Gambacorti-Passerini 1, 3 , Luca Mologni 1
中文翻译：
将培美替尼重新用作 TKI 耐药 BCR::ABL1 抑制剂
更新日期：2024-05-15
Leukemia ( IF 12.8 ) Pub Date : 2024-05-15 , DOI: 10.1038/s41375-024-02282-y Diletta Fontana 1 , Federica Malighetti 1 , Matteo Villa 1 , Alfonso Zambon 2 , Carlo Gambacorti-Passerini 1, 3 , Luca Mologni 1
Affiliation
|
中文翻译：
将培美替尼重新用作 TKI 耐药 BCR::ABL1 抑制剂
京公网安备 11010802027423号